Secondary pre-leukaemia and etoposide.
D005047:Etoposide / Q000009:adverse effects*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced*; D008479:Mediastinal Neoplasms / Q000188:drug therapy; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D009436:Neural Tube Defects / Q000139:chemically induced*
D005047:Etoposide